Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Francesca Capon headshot

Francesca

Capon

,

PhD

Donald Rix BC Leadership Chair in Genetic Medicine
University of British Columbia
Vancouver
,
British Columbia
,
Canada
Councilor Since: September 1, 2018
IPC Councilor
Dr. Francesca Capon obtained a BSc in biological sciences (1992) and a PhD in medical genetics (1999) from La Sapienza, University of Rome, Italy. Her interest in the genetics of psoriasis brought her to the United Kingdom. She first moved to the University of Leicester as a Wellcome Trust Research Fellow (2001), then took on a Lectureship in human molecular genetics at University College London (2004). She joined King’s College London in 2006 as a lecturer and was then promoted to Senior Lecturer (2014), Reader (Associate Professor, 2018) and Professor (2022). In 2024, she moved to the University of British Columbia (Vancouver, Canada), where she is the Donald Rix Leadership Chair in Genetic Medicine. In recent years, the Capon Lab has been concentrating on two main research areas: the identification of disease pathways in pustular forms of psoriasis and the determinants of drug response in plaque psoriasis. This research has been published in high-impact journals, including the American Journal of Human Genetics, the Journal of Allergy and Clinical Immunology, Science Translational Medicine, and Nature Communications.
Last Updated:
11/11/2024

Areas of Interest

Genetics and transcriptomics.

IPC Committees / Groups

Palmoplantar Pustulosis (PPP) Working Group

Languages Spoken

English, French

Involvement with Other Organization(s)

Contributed to events organised by the Psoriasis Association of the United Kingdom.

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026